PMID: 6986967Feb 15, 1980Paper

A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma

Cancer
S B Murphy, H O Hustu

Abstract

From 1975 to 1978, 69 children with non-Hodgkin's lymphoma were staged and treated in a randomized protocol to determine the contribution of involved-field radiotherapy (IF-RT) to an effective drug regimen in Stages III-IV and the efficacy of prophylactic treatment of the central nervous system with cranial irradiation and intrathecal methotrexate in Stage II-IV. Induction therapy for Stages I-II was vincristine, prednisone, cyclophosphamide and IF-RT (3000-3500 rad). Stages III-IV received the same three drugs plus adriamycin, and were randomized to received or not receive IF-RT. The complete remission rate was 88%. After randomization to receive CNS prophylaxis or not, all children received oral mercaptopurine and methotrexate for 18 months. The two-year actuarial estimate of disease-free survival for all responders is 55% and is significantly influenced by stage. (Ninety percent disease-free survival for Stages I-II, versus 38.8% for III-IV, P less than .05). We observed no benefit but added toxicity from IF-RT in Stages III-IV. Efforts at CNS prophylaxis in high-risk children are warranted, since only 1 of 18 children randomized to receive prophylaxis developed CNS disease as the site of first relapse, whereas 4 of 16 recei...Continue Reading

References

Apr 26, 1975·Lancet·G P CanellosR E Johnson
May 1, 1978·Cancer·M L BrecherA I Freeman
Dec 29, 1977·The New England Journal of Medicine·W T HughesS L George
Nov 1, 1977·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B M LauR J Haas
Oct 1, 1974·Cancer·R J Lukes, R D Collins

❮ Previous
Next ❯

Citations

Mar 1, 1993·Indian Journal of Pediatrics·S H Advani
Apr 1, 1995·American Journal of Surgery·G A Turowski, M D Basson
Nov 15, 2002·Survey of Ophthalmology·Sarah E CouplandHarald Stein
Sep 24, 1981·The New England Journal of Medicine·J L Ziegler
May 9, 1996·The New England Journal of Medicine·J T SandlundW M Crist
Nov 5, 1997·The New England Journal of Medicine·M P LinkS B Murphy
Nov 5, 1997·The New England Journal of Medicine·I Magrath
Jun 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J T SandlundR C Ribeiro
Nov 5, 1997·Annals of the New York Academy of Sciences·I T Magrath
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Clare StannardV Bala Reddi
Oct 1, 1986·Archives of Disease in Childhood·A Al-AttarA Attra
Dec 29, 2000·Pediatric Hematology and Oncology·C KaradenizO Akhan
Mar 1, 2006·Expert Review of Anticancer Therapy·John Gerecitano, David J Straus
Jan 1, 1993·Medical and Pediatric Oncology·V VecchiG Paolucci
Jan 1, 1991·Medical and Pediatric Oncology·C KaradenizA Doğan
Aug 1, 1994·American Journal of Hematology·V A MorrisonB A Peterson
Sep 1, 1991·American Journal of Hematology·R D Mashal, G P Canellos
Jan 1, 1993·Auris, Nasus, Larynx·H NaganumaK Iwabuchi
Mar 1, 1987·International Journal of Radiation Oncology, Biology, Physics·L R MandellZ Fuks
Jun 19, 2007·American Journal of Hematology·Amane YamauchiKatsuyuki Aozasa
Mar 1, 1988·The American Journal of Medicine·L RechtJ B Posner
Sep 1, 1989·Disease-a-month : DM·E R Gaynor, R I Fisher
Feb 1, 1992·Journal of Pediatric Surgery·R C Shamberger, H J Weinstein
Oct 1, 1985·European Journal of Cancer & Clinical Oncology·T SumerM Al-Mouzan
Jul 1, 1992·Critical Reviews in Oncology/hematology·L WhiteT C Quah
Jan 1, 1989·Medical and Pediatric Oncology·J L FinlayS Frierdich
Jan 1, 1981·Medical and Pediatric Oncology·V VecchiG Paolucci
Jan 1, 1986·Seminars in Surgical Oncology·M L Brecher
May 1, 1986·Seminars in Oncology Nursing·A Nirenberg, C F Bridgewater
May 1, 1992·Clinical Oncology : a Journal of the Royal College of Radiologists·K R MuirA H Cameron

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.